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Chronic low-grade, systemic inﬂammation is a well-characterized risk factor in the development of chronic metabolic diseases,
such as cardiovascular disease, type 2 diabetes, and metabolic syndrome. Diet could be an eﬀective strategy for reducing
inﬂammation associated with chronic disease. While anti-inﬂammatory properties of isolated dietary bioactive and functional
foods have been routinely studied, the evaluation of dietary patterns on inﬂammation warrants further review—especially given
the recent inclusion of dietary pattern recommendations into dietary guidelines and policies. Therefore, the objective of this
narrative review is to examine current evidence linking diet to low-grade, systemic inﬂammation within the context of chronic
disease. Speciﬁcally, we provide an update on the ﬁndings from human trials that have characterized anti-inﬂammatory
properties of dietary patterns, deﬁned by various methods and indexes. Given the complexity of interpreting results from dietary
pattern analysis, we further present recent evidence on the anti-inﬂammatory roles of isolated bioactive nutrients and functional
foods that are common components of distinct dietary patterns, in addition to considerations for interpreting dietary pattern
research, population-speciﬁc dietary recommendations, and future studies. Overall, we observe a vast range of variability in the
evidence from observational studies that have evaluated the relationships between healthy dietary patterns and inﬂammatory
markers. These studies highlight the need for additional intervention studies with study designs that account for metabolic
status, diversity in populations, breadth of inﬂammatory measurements, fasting vs. postprandial eﬀects of diet, and control of
confounding factors (e.g., genotype, microbiome proﬁles, and dietary adherence) in order to better understand the eﬀect that
diet has, as a whole, on inﬂammation. These strategies will help to strengthen diet recommendations aimed at reducing
inﬂammation and chronic disease risk.
1. Introduction
Chronic low-grade, systemic inﬂammation is a distinctive
feature present in the development of metabolic and cardio-
vascular diseases (CVD) [1–4]. Considering the mounting
health care cost [5] and prevalence [6] of chronic diseases,
it is essential to better understand how to ameliorate
inﬂammation.
Low-grade, systemic inﬂammation is characterized by
a two to threefold increase in concentrations of cytokines
in the bloodstream, such as tumor necrosis factor alpha
(TNF-α), interleukin-6 (IL-6) [7], and high-sensitivity
C-reactive protein (hsCRP)—a well-established biomarker
of inﬂammation and CVD risk [8]. Additionally, other
interleukins (e.g., IL-1β, IL-4, IL-8, and IL-10), and adhesion
molecules (e.g., vascular cell adhesion molecule 1 (VCAM1)
and intracellular adhesion molecule 1 (ICAM1)) also con-
tribute to the determination of an individual’s inﬂammatory
status [9, 10].
The origins of low-grade, systemic inﬂammation are
multifactorial and often stem from obesity-induced meta-
bolic tissue dysfunction and/or the failure of immune cells
to adequately ameliorate proinﬂammatory responses [11].
The production of inﬂammatory mediators is an essential
mechanism by which leukocytes confer immune protection
in response to infectious pathogens and tissue injury. Acute
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inﬂammatory responses begin with the activation of innate
immune cells (e.g., macrophages, monocytes, and granulo-
cytes), followed by highly speciﬁc and coordinated activation
of adaptive immune cell populations (e.g., T and B lympho-
cytes) [12, 13]. Upon clearance of the initial immune insult,
subsequent production of anti-inﬂammatory cytokines and
eicosanoids is critical to ensure resolution of inﬂammation,
prevent prolonged proinﬂammatory responses, promote
tissue healing, and facilitate a return to homeostatic tissue
function [14]. In obesity, excessive weight gain leads to adi-
pose tissue remodeling, which includes increases in adipocyte
hypertrophy, hypoxia, stress, and apoptosis/necrosis [15].
Activation and recruitment of proinﬂammatory leukocytes
perpetuate the prolonged production of inﬂammatory medi-
ators, whereas the subsequent release of adipose-derived
proinﬂammatory cytokines and free fatty acids into the
circulation can lead to widespread metabolic dysfunction
[16]. Together, systemic disturbances in metabolism and
tissue health promote chronic low-grade inﬂammation and
increased risk for chronic disease [17].
Dietary intake modulates inﬂammation and represents
an eﬀective and promising therapeutic target to reduce met-
abolic dysfunction and chronic disease risk [17–19]. The
eﬀect of diet on inﬂammation has been extensively analyzed
by studying isolated bioactive nutrients (ﬁber [20], fatty acids
[21], and polyphenols [22, 23]) and functional whole foods
(eggs [24] and blueberries [25]). However, recent studies
highlight the value of characterizing the relationship between
diet and inﬂammation through assessment of dietary pat-
terns [11, 26, 27]. A dietary pattern can be described as a
comprehensive dietary evaluation in which multiple foods
and/or nutrients are examined collectively [28]. Studying
dietary patterns can be complex and challenging, in part
due to the diversity of patterns within diﬀerent cultures and
populations, in addition to the inherent heterogeneity of
physiological responses to diet due to variability in genetics,
microbiome proﬁles, metabolic status, etc. [29]. However,
dietary patterns additionally have a great potential for trans-
lation to the general public, as evidenced by the inclusion of
dietary pattern recommendations in the 2015-2020 Dietary
Guidelines for Americans [23].
The objective of the present narrative review is to exam-
ine current evidence linking diet to low-grade, systemic
inﬂammation within the context of chronic disease. Speciﬁ-
cally, we provide an update on the ﬁndings from human
trials within the past 5 years (2014–present) that have charac-
terized anti-inﬂammatory properties of dietary patterns,
deﬁned by various methods and indexes. Given the complex-
ity of interpreting results from dietary pattern analysis, we
further present recent evidence on the anti-inﬂammatory
roles of isolated bioactive nutrients and functional foods that
are common components of distinct dietary patterns, in
addition to considerations for interpreting dietary pattern
research, population-speciﬁc dietary recommendations, and
future studies.
The literature search performed in Scopus and PubMed
included the following keywords and its combinations:
dietary patterns, food patterns, diet, dietary inﬂammatory
index, foods, anti-inﬂammatory foods, anti-inﬂammatory
nutrients/inﬂammation, inﬂammatory markers, CRP, bio-
markers of inﬂammation, cytokines, low-grade, systemic
inﬂammation, and adipokines. The criteria encompassed
the inclusion of only peer-reviewed human studies initially
from 2016 to present time. Then, a second search expanded
the years from 2014 to present to provide a more comprehen-
sive assessment of dietary patterns within the context of
inﬂammatory biomarkers and chronic disease.
2. Evaluation of Inflammatory Dietary Patterns
Utilizing Dietary Indexes
In order to evaluate diet quality in relation to inﬂammation,
researchers have developed various methods to establish
measurable dietary patterns. Reedy et al. [29] refer to dietary
patterns as a way of conceptualizing numerous diet exposures
as a multidimensional construct. For example, Western-style
dietary patterns that are rich in reﬁned carbohydrates,
sodium, and trans- and saturated fatty acids (SFA) have
additionally been linked with higher levels of inﬂamma-
tory markers, which in turn increase CVD risk [30–32].
Conversely, Mediterranean-style dietary patterns that are
rich in ﬁber, lean protein, monounsaturated (MUFA), and
omega-3 polyunsaturated fatty acids (PUFA) are anti-
inﬂammatory and cardioprotective [33–35].
Dietary patterns can be derived using principal compo-
nent analysis, reduced rank regression, and index-based
methods, such as the Healthy Eating Index (HEI) score, the
Empirical Dietary Inﬂammatory Index (EDII) [36], or the
Diet Inﬂammatory Index (DII) [37]. The HEI compares a
given diet to the American dietary guidelines as the gold
standard [38]. The EDII and, the more widely used, DII are
a posteriori approaches to examine the inﬂammatory poten-
tial of a diet [36]. Each method provides a unique prospective
in evaluating the eﬀects of diet on inﬂammation.
2.1. Healthy Eating Index (HEI) Score.A better quality diet, as
shown with adherence to dietary guidelines, is associated
with lower inﬂammatory markers, data from the Women’s
Health Initiative study [39] and data from the Malmo Diet
and Cancer study [40]. Similarly, an observational cohort in
South America used the principal component analysis to
compare 2 dietary patterns. The “prudent” dietary pattern,
characterized by a higher intake of fruits, vegetables, seafood,
whole grain cereals, and low-fat dairy products, was associ-
ated with reduced plasma CRP for men compared to the
“Western” (standard U.S.) dietary pattern [32]. Researchers
calculated the HEI for an 8-week weight loss intervention
in obese people diagnosed with metabolic syndrome [41].
Changes in the HEI were associated with changes in gene
expression of inﬂammatory markers [41, 42].
2.2. Empirical Dietary Inﬂammatory Index (EDII). The EDII
uses reduced rank regression to derive a dietary pattern
based on food groups. These food groups were positively
associated with inﬂammatory markers, a.k.a. “proinﬂamma-
tory”: processed meat, red meat, other vegetable-reﬁned
grains, high-energy beverages, low-energy beverages, and
tomatoes and the following were inversely associated: dark
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yellow vegetables, leafy green vegetables, snacks, fruit juice,
pizza, beer, wine, tea, and coﬀee. In the study of dietary
patterns, it is the combination of these food groups, not each
of them individually, that reveal these associations [36]. This
index was validated using the data from the Nurses’ Health
Study I (NHS), NHS-II, and the Health Professionals
Follow-Up Study, with only male subjects [36]. Tabung
et al. [36] reported stronger associations between the EDII
and IL-6, CRP, and the overall inﬂammatory marker scores
in men of normal weight when compared to overweight/
obese men. The authors suggested that the EDII, which they
also called the Empirical Diet Inﬂammatory Pattern (EDIP),
needs to be reproduced in multiethnic/multiracial popula-
tions [36]. Thus, the same research group [43] performed a
cross-sectional study using the data from the Women’s
Health Initiative observational study and calculated EDIP
scores using baseline food frequency questionnaire data
from 31,472 women, aged 50-79 yrs. Authors reported that
independent of energy intake, BMI, and physical activity,
higher EDIP scores were signiﬁcantly associated with higher
(lower for adiponectin) absolute concentrations of all
inﬂammatory biomarkers (CRP, IL-6, TNF-α, and TNF-α
receptors 1 and 2) [43]. In a report by Soltani et al.
[44], a cross-sectional study performed in 403 middle-
agedIranians used the same method to examine the rela-
tionship between an “inﬂammatory dietary pattern” and
the odds of an unhealthy phenotype among overweight/-
obese adults. Authors concluded that there were associa-
tions between the “inﬂammatory dietary pattern” and the
unhealthy phenotype (high fasting blood sugar, and
low-HDL-C), but that they were dependent on the
energy intake [44].
2.3. Diet Inﬂammatory Index (DII). The Dietary Inﬂamma-
tory Index (DII) uses a principal component analysis to
categorize an individual’s diet as anti- or proinﬂammatory,
based on the capacity of diets to modulate systemic inﬂam-
matory biomarkers [37]. Food parameters were assigned
scores based on research (1943 articles) describing the rela-
tionship between those parameters and inﬂammation. DII
was validated with the data from the Asklepios Study [42],
NHANES 2005-10 [45], and the Northern Sweden Health
and Disease Study [46]. A proinﬂammatory diet (based on
the DII) is associated with increased all-cause mortality
according to a recent report from two European large cohort
studies, the SUN and PREDIMED trials [47]. Recently
(2018), the association of DII with depressive symptoms
remained after the Framingham Risk Score (FRS) adjust-
ment, suggesting a relationship between the inﬂammatory
potential of the diet and depression [48]. Phillips et al. [49]
reported that individuals with higher Energy-adjusted DII
(E-DII) scores displayed several features of the metabolic
syndrome (MetS). Similarly, the higher inﬂammatory poten-
tial of diet denoted higher values of serum lipids, CRP and
kidney function tests, and a higher EuroSCORE as a pre-
dictor of postoperative mortality among patients who are
candidates for coronary artery bypass grafting (CABG)
[50]. Taken together, there are several contemporary
reports of studies using the DII scores to improve the
understanding of dietary patterns and inﬂammation in
healthy and diseased individuals.
2.4. Mediterranean-Style Dietary Patterns. Concerning the
type of diet, there is mounting epidemiological evidence
that speciﬁc dietary patterns, such as adherence to
Mediterranean-style dietary patterns, are anti-inﬂammatory
and concomitantly protective against CVD. Additionally,
this diet can also beneﬁt coronary artery disease (CAD)
patients [35, 51, 52].
Waldeyer et al. [35] analyzed adherence to theMediterra-
nean diet using the INTERCATH cohort data. This cohort
consisted of 70% of participants being male, diagnosed with
CAD, and aged 61-77 yrs. A higher adherence was indepen-
dently associated with less CAD severity. Supporting the
anti-inﬂammatory role of the diet, hsCRP inversely corre-
lated with adherence to the Mediterranean diet. Conversely,
a 6-month intervention trial testing the Mediterranean diet
vs. a low-fat diet did not result in decreases in CRP or IL-6
for Australians diagnosed with CAD [51]. Researchers calcu-
lated the DII score for each diet, and those following the
Mediterranean diet improved by lowering their DII score
(the lower, the more anti-inﬂammatory). The small sample
size, (n = 27 per group) and the fact that some participants
had a normal hsCRP at baseline, could contribute to the
discrepancy in translating population-based eﬀects into
clinical changes in plasma biomarkers.
The Moli-sani study (cohort of 24,325 men and
women) showed that adherence to a “Mediterranean-like
Diet” was associated with lower hsCRP, blood platelets,
and white blood cell counts [53]. On the other hand,
adherence to a DASH diet, but not the Mediterranean
diet, was associated with lower hsCRP in a group of 320
overweight Iranian females [52]. There are some similari-
ties within these diets, speciﬁcally related to the emphasis
in fruits and vegetables.
3. Isolated Bioactive Nutrients and
Functional Foods
As described above, the impact of dietary patterns in modu-
lating inﬂammation is due to complex interactions between
functional foods and nutrients with bioactive properties.
Accordingly, it is important to evaluate the eﬀects of isolated
nutrients, macronutrient distributions, and whole foods that
are common components of distinct dietary patterns in
order to characterize the contributions of each dietary fac-
tor. This information may be important in predicting the
eﬀects of dietary patterns in cases where dietary allergies,
intolerances, or food preferences may prevent individuals
from consuming the full range of components that com-
prises a distinct dietary pattern. In this section, we present
recent studies that evaluate the eﬀect of one macronutrient,
which in turn aﬀects macronutrient distribution (Table 1).
We further review recent studies that analyze the eﬀects
of isolated nutrients and whole food components, such as
ﬁber, phospholipids, SFA, omega-3 PUFA, and polyphenol-
rich extracts (Table 2).
3Disease Markers
T
a
bl
e
1:
M
ac
ro
nu
tr
ie
nt
di
st
ri
bu
ti
on
,d
ie
ta
ry
pa
tt
er
ns
,a
nd
in
ﬂ
am
m
at
or
y
m
ar
ke
rs
.
A
ut
ho
rs
,c
ou
nt
ry
&
ye
ar
St
ud
y
de
si
gn
/d
ur
at
io
n
P
ar
ti
ci
pa
nt
s
D
ie
t
ev
al
ua
te
d
In
ﬂ
am
m
at
or
y
m
ar
ke
rs
/a
di
po
ki
ne
s
(m
ea
su
re
d
in
fa
st
in
g
pl
as
m
a)
R
es
ul
ts
Ju
an
ol
a-
Fa
lg
ar
on
a,
et
al
.[
57
]
Sp
ai
n,
20
14
R
C
T
,w
ei
gh
t
lo
ss
st
ud
y/
6
m
o.
G
LY
N
D
IE
T
st
ud
y
n
=
10
5,
m
en
an
d
w
om
en
,a
ge
d
30
an
d
60
yr
s.
B
M
I
ra
ng
e
27
-3
5
M
od
er
at
e
C
H
O
an
d
hi
gh
gl
yc
em
ic
in
de
x
vs
.m
od
er
at
e
C
H
O
an
d
LG
I
vs
.a
lo
w
-f
at
an
d
H
G
I
di
et
.
50
0
kc
al
/d
su
bt
ra
ct
ed
of
to
ta
l
en
er
gy
fo
r
ea
ch
pa
rt
ic
ip
an
t
P
A
I-
1,
C
R
P
,I
L-
6,
M
C
P
-1
,
IC
A
M
-1
,a
nd
ad
ip
on
ec
ti
n
(1
)
N
o
di
ﬀ
er
en
ce
s
in
an
y
of
th
e
in
ﬂ
am
m
at
or
y
m
ar
ke
rs
be
tw
ee
n
gr
ou
ps
.
(2
)
A
re
du
ct
io
n
in
C
R
P
va
lu
es
fo
r
th
e
LG
I
gr
ou
p
pr
e
vs
.p
os
ti
nt
er
ve
nt
io
n,
lik
el
y
dr
iv
en
by
th
e
gr
ea
te
r
w
ei
gh
t
lo
ss
.
Jo
na
ss
on
et
al
.[
55
]
Sw
ed
en
,2
01
4
C
lin
ic
al
tr
ia
l.
W
ei
gh
tl
os
s
in
te
rv
en
ti
on
w
it
h
co
nt
ro
l
gr
ou
p/
24
m
o.
n
=
61
in
te
rv
en
ti
on
gr
ou
p
(T
2D
)
an
d
n
=
41
co
nt
ro
lg
ro
up
(h
ea
lth
y)
LF
D
ai
m
in
g
30
%
fr
om
fa
tv
s.
a
LC
D
ai
m
in
g
20
%
C
H
O
IL
-1
β
,I
L-
1R
a,
IL
-6
,
T
N
FR
s,
an
d
C
R
P
at
ba
se
lin
e
an
d
6
m
o.
(1
)
B
ot
h
di
et
s
le
d
to
si
m
ila
r
re
du
ct
io
ns
in
bo
dy
w
ei
gh
t;
ho
w
ev
er
,o
nl
y
th
e
LC
D
im
pr
ov
ed
in
su
lin
se
ns
it
iv
it
y.
(2
)
A
ft
er
6
m
o.
,I
L-
1R
a
an
d
IL
-6
w
er
e
lo
w
er
in
th
e
LC
D
.
Sa
nt
ia
go
T
or
re
s
et
al
.[
58
]
U
S,
20
15
C
oh
or
t.
Su
bs
et
sa
m
pl
e
of
th
e
W
om
en
’s
H
ea
lth
In
it
ia
ti
ve
st
ud
y
n
=
49
3,
m
id
dl
e-
ag
ed
w
om
en
of
M
ex
ic
an
de
sc
en
t
A
dh
er
en
ce
to
a
“c
re
at
ed
tr
ad
it
io
na
lM
ex
ic
an
di
et
”
hs
C
R
P
(1
)
A
t
fo
llo
w
-u
p,
(1
5
y)
hs
C
R
P
w
as
22
%
lo
w
er
in
w
om
en
w
ho
ha
d
hi
gh
co
m
pa
re
d
to
lo
w
or
m
od
er
at
e
M
ex
D
sc
or
es
.
(2
)
W
om
en
w
it
h
hi
gh
M
ex
D
sc
or
es
w
er
e
m
or
e
lik
el
y
to
be
no
rm
al
w
ei
gh
t
at
ba
se
lin
e.
D
ia
s
et
al
.[
40
]
Sw
ed
en
,2
01
5
C
ro
ss
-s
ec
ti
on
al
.D
at
a
fr
om
th
e
M
al
m
o
D
ie
t
an
d
C
an
ce
r
st
ud
y
n
=
66
7,
ag
ed
63
-6
8
yr
s.
D
ie
t
qu
al
it
y
in
de
x,
ad
he
re
nc
e
to
th
e
Sw
ed
is
h
N
ut
ri
ti
on
R
ec
om
m
en
da
ti
on
IL
1-
be
ta
,I
L-
8,
T
N
F-
α
,a
nd
hs
C
R
P
. M
on
on
uc
le
ar
le
uk
oc
yt
es
.I
nﬂ
am
m
at
or
y
pr
ot
ei
n
S1
00
A
8/
9
T
ho
se
w
ho
re
po
rt
ed
a
hi
gh
er
qu
al
it
y
di
et
ha
d
lo
w
er
le
ve
ls
of
T
N
F-
α
,h
sC
R
P
,
no
nc
la
ss
ic
al
m
on
oc
yt
es
,a
nd
in
ﬂ
am
m
at
or
y
pr
ot
ei
n
S1
00
A
8/
9,
af
te
r
ad
ju
st
in
g
fo
r
ag
e,
ge
nd
er
,s
m
ok
in
g,
P
A
,t
ot
al
en
er
gy
,W
C
,
an
d
se
as
on
of
th
e
di
et
re
po
rt
ed
.
M
ar
qu
es
-R
oc
ha
et
al
.[
41
]
Sp
ai
n,
20
16
R
C
T
,w
ei
gh
t
lo
ss
in
te
rv
en
ti
on
/8
w
ee
ks
n
=
40
,o
be
se
w
it
h
M
et
S.
Su
bs
am
pl
e
of
th
e
R
E
SM
E
N
A
-S
H
yp
oc
al
or
ic
di
et
ba
se
d
on
th
e
M
ed
it
er
ra
ne
an
di
et
,3
0%
en
er
gy
re
st
ri
ct
io
n,
in
cr
ea
se
d
m
ea
lf
re
qu
en
cy
,a
nd
7
d
m
en
u
pl
an
pr
ov
id
ed
.H
ea
lth
y
E
at
in
g
In
de
x
w
as
ca
lc
ul
at
ed
.
M
D
A
,C
R
P
,I
L-
6,
P
A
I-
1,
an
d
T
N
F-
α
ex
pr
es
si
on
of
in
ﬂ
am
m
at
io
n-
re
la
te
d
ge
ne
s:
IL
-6
,I
L-
18
,T
N
F-
α
,
an
d
sI
C
A
M
,S
E
R
P
IN
E
1,
V
C
A
M
-1
G
A
P
D
H
,a
nd
m
iR
N
A
s
in
W
B
C
(1
)
N
o
ch
an
ge
s
in
pl
as
m
a
C
R
P
,I
L-
6,
an
d
T
N
F-
α
,b
ut
th
er
e
w
as
a
re
du
ct
io
n
in
M
D
A
an
d
P
A
I-
1
af
te
r
8
w
ee
ks
.
(2
)
Lo
w
er
co
ns
um
pt
io
n
of
lip
id
s
an
d
sa
tu
ra
te
d
fa
t
w
as
as
so
ci
at
ed
w
it
h
in
cr
ea
se
d
le
t-
7b
af
te
r
nu
tr
it
io
na
l
in
te
rv
en
ti
on
.
So
ng
et
al
.[
59
]
U
S,
20
16
P
ar
al
le
ld
es
ig
n/
6
w
ee
ks
.
R
C
T
fe
ed
in
g
st
ud
y
n
=
92
,h
ea
lth
y,
ag
ed
21
-7
6
yr
s.
,B
M
I
19
.2
-3
5.
5
E
uc
al
or
ic
m
od
er
at
e
fa
t
di
et
(3
6%
fa
t/
46
%
C
H
O
vs
.
eu
ca
lo
ri
c
lo
w
-f
at
/h
ig
h
C
H
O
(1
8%
fa
t/
64
%
C
H
O
vs
.l
ow
ca
lo
ri
es
33
%
re
du
ct
io
n
of
th
e
LF
D
)
IL
-6
,T
N
FR
s,
C
R
P
,l
ep
ti
n,
an
d
ad
ip
on
ec
ti
n
at
ba
se
lin
e
an
d
6
w
ee
ks
(1
)
N
o
ch
an
ge
s
in
pl
as
m
a
in
ﬂ
am
m
at
or
y
m
ar
ke
rs
af
te
r
6
w
ee
ks
of
M
FD
,L
FD
,a
nd
lo
w
-c
al
or
ie
LF
D
.A
m
od
es
t
w
ei
gh
t
re
du
ct
io
n
w
as
ob
se
rv
ed
in
th
e
re
st
ri
ct
ed
ca
lo
ri
e
di
et
an
d
ad
ip
on
ec
ti
n
re
du
ct
io
n
w
as
re
po
rt
ed
fo
r
th
e
eu
ca
lo
ri
c
LF
D
vs
.M
FD
.
4 Disease Markers
T
a
bl
e
1:
C
on
ti
nu
ed
.
A
ut
ho
rs
,c
ou
nt
ry
&
ye
ar
St
ud
y
de
si
gn
/d
ur
at
io
n
P
ar
ti
ci
pa
nt
s
D
ie
t
ev
al
ua
te
d
In
ﬂ
am
m
at
or
y
m
ar
ke
rs
/a
di
po
ki
ne
s
(m
ea
su
re
d
in
fa
st
in
g
pl
as
m
a)
R
es
ul
ts
M
ay
r
et
al
.[
51
]
A
us
tr
al
ia
,2
01
8
M
ul
ti
ce
nt
er
,p
ar
al
le
l
de
si
gn
,r
an
do
m
iz
ed
,
6-
m
on
th
in
te
rv
en
ti
on
an
d
12
-m
on
th
fo
llo
w
-u
p.
A
U
SM
E
D
St
ud
y
n
=
29
fo
r
M
ed
D
ie
t
an
d
n
=
27
fo
r
lo
w
-f
at
di
et
.
P
at
ie
nt
s
w
it
h
C
A
D
M
ed
D
ie
t
vs
.l
ow
-f
at
di
et
.M
ed
Di
et
=
42
%
fa
t
(a
t
le
as
t
50
%
w
as
fr
om
M
U
FA
an
d
25
%
fr
om
P
U
FA
,<
10
%
sa
tu
ra
te
d
fa
tt
y
ac
id
s)
,3
5%
C
H
O
Lo
w
-f
at
di
et
=
<3
0%
to
ta
l
fa
t,
<7
%
sa
tu
ra
te
d
fa
t,
45
–6
5%
C
H
O
hs
C
R
P
an
d
IL
-6
(1
)
T
he
re
w
er
e
no
ch
an
ge
s
in
pl
as
m
a
hs
C
R
P
or
IL
-6
af
te
r
6
m
on
th
s
fo
r
ei
th
er
di
et
.
(2
)
Fo
llo
w
in
g
th
e
M
ed
D
ie
t,
bu
t
no
t
th
e
lo
w
-f
at
di
et
,l
ea
ds
to
si
gn
iﬁ
ca
nt
re
du
ct
io
n
in
th
e
D
II
sc
or
e.
Sa
kh
ae
ie
t
al
.[
52
]
Ir
an
,2
01
8
C
ro
ss
-s
ec
ti
on
al
n
=
32
0,
Y
az
di
fe
m
al
e
te
ac
he
rs
,a
ge
d
25
-5
0
yr
s.
Sa
m
pl
e
st
ra
ti
ﬁ
ed
in
te
rt
ile
s
A
dh
er
en
ce
to
D
A
SH
di
et
an
d
th
e
M
ed
it
er
ra
ne
an
di
et
ba
se
d
on
pu
bl
is
he
d
sc
or
in
g
m
et
ho
d
hs
C
R
P
an
d
IL
-1
7A
A
dh
er
en
ce
to
th
e
D
A
SH
di
et
w
as
si
gn
iﬁ
ca
nt
ly
as
so
ci
at
ed
w
it
h
re
du
ce
d
se
ru
m
hs
C
R
P
on
ly
.A
dh
er
en
ce
to
th
e
M
ed
it
er
ra
ne
an
di
et
m
ig
ht
be
as
so
ci
at
ed
w
it
h
lo
w
er
ci
rc
ul
at
in
g
IL
-1
7A
co
nc
en
tr
at
io
ns
,b
ut
no
t
hs
C
R
P
le
ve
ls
in
th
is
gr
ou
p
of
fe
m
al
es
.
Sh
iv
ap
pa
et
al
.[
60
]
It
al
y,
20
18
C
ro
ss
-s
ec
ti
on
al
.D
at
a
fr
om
M
ol
i-
sa
ni
st
ud
y
n
=
20
82
3,
ad
ul
ts
,a
ge
d
ov
er
35
yr
s.
,4
8%
m
al
e
w
it
ho
ut
ac
ut
e
in
ﬂ
am
m
at
io
n
D
II
ca
lc
ul
at
ed
us
in
g
da
ta
on
on
ly
34
nu
tr
ie
nt
s
an
d
ot
he
r
fo
od
co
m
po
ne
nt
s
de
ri
ve
d
fr
om
th
e
FF
Q
.
IN
FL
A
-s
co
re
in
cl
ud
es
pl
at
el
et
an
d
le
uk
oc
yt
e
co
un
ts
,t
he
gr
an
ul
oc
yt
e
to
ly
m
ph
oc
yt
e
ra
ti
o,
an
d
C
R
P
.
T
he
re
w
as
a
po
si
ti
ve
as
so
ci
at
io
n
be
tw
ee
n
D
II
an
d
IN
FL
A
-s
co
re
,a
m
on
g
th
os
e
ag
ed
50
to
65
yr
s.
,b
ut
no
t
fo
r
th
os
e
ol
de
r
th
an
65
yr
s.
N
o
as
so
ci
at
io
n
be
tw
ee
n
D
II
an
d
C
R
P
al
on
e.
A
bb
re
vi
at
io
ns
.A
U
SM
E
D
:A
us
tr
al
ia
n
M
ed
it
er
ra
ne
an
di
et
he
ar
tt
ri
al
;D
II
:d
ie
ta
ry
in
ﬂ
am
m
at
or
y
in
de
x;
FF
Q
:f
oo
d
fr
eq
ue
nc
y
qu
es
ti
on
na
ir
e;
H
G
I:
hi
gh
gl
yc
em
ic
in
de
x;
LC
D
:l
ow
ca
rb
oh
yd
ra
te
di
et
;L
FD
:l
ow
-f
at
di
et
;
LG
I:
lo
w
gl
yc
em
ic
in
de
x;
M
ed
D
ie
t:
M
ed
it
er
ra
ne
an
di
et
;M
ex
D
:M
ex
ic
an
di
et
;M
FD
:m
od
er
at
e-
fa
t
di
et
;R
E
SM
E
N
A
-S
:t
he
m
et
ab
ol
ic
sy
nd
ro
m
e
re
du
ct
io
n
in
N
av
ar
ra
st
ud
y;
W
C
:w
ai
st
ci
rc
um
fe
re
nc
e.
5Disease Markers
T
a
bl
e
2:
Si
ng
le
nu
tr
ie
nt
s
an
d
in
ﬂ
am
m
at
or
y
m
ar
ke
rs
.
A
ut
ho
rs
/o
ri
gi
n/
ye
ar
St
ud
y
de
si
gn
/d
ur
at
io
n
P
ar
ti
ci
pa
nt
s
N
ut
ri
en
t
In
ﬂ
am
m
at
or
y
m
ar
ke
rs
m
ea
su
re
d
R
es
ul
ts
T
eu
ni
ss
en
-B
ee
km
an
et
al
.[
61
]
E
ng
la
nd
,2
01
5
(1
)
P
os
tp
ra
nd
ia
ls
tu
dy
/1
2
H
(2
)
C
ro
ss
ov
er
,r
an
do
m
iz
ed
pa
ra
lle
lg
ro
up
de
si
gn
/4
w
ee
ks
ea
ch
.
D
at
a
fr
om
th
e
P
R
O
P
R
E
S
st
ud
y
(1
)
P
os
tp
ra
nd
ia
ls
tu
dy
n
=
52
(2
)
C
ro
ss
ov
er
st
ud
y
n
=
48
,
ov
er
w
ei
gh
t/
ob
es
e
w
it
h
un
tr
ea
te
d
bl
oo
d
pr
es
su
re
.
(1
)
P
os
tp
ra
nd
ia
lr
es
po
ns
es
af
te
r
m
al
to
de
xt
ri
n
(s
ha
ke
)
vs
.
su
cr
os
e
vs
.a
sp
ec
iﬁ
c
pr
ot
ei
n
m
ix
tu
re
(p
ea
,m
ilk
,a
nd
eg
g
w
hi
te
pr
ot
ei
n)
.
(2
)
Fo
ur
w
ee
ks
of
ex
ch
an
gi
ng
3x
20
g/
d
of
C
H
O
is
oe
ne
rg
et
ic
al
ly
w
it
h
a
pr
ot
ei
n
m
ix
.
SA
A
,C
R
P
,a
nd
sI
C
A
M
.F
as
ti
ng
an
d
po
st
pr
an
di
al
(a
t
4
H
)
(1
)
P
os
tp
ra
nd
ia
lC
R
P
le
ve
ls
w
er
e
hi
gh
er
4
H
af
te
r
in
ge
st
io
n
of
th
e
pr
ot
ei
n
m
ix
co
m
pa
re
d
to
m
al
to
de
xt
ri
n,
bu
t
th
er
e
w
er
e
no
di
ﬀ
er
en
ce
s
in
sI
C
A
M
an
d
SA
A
.
P
os
tp
ra
nd
ia
ls
IC
A
M
le
ve
ls
w
er
e
lo
w
er
af
te
r
pe
a
pr
ot
ei
n
vs
.
eg
g
pr
ot
ei
n.
(2
)
Si
gn
iﬁ
ca
nt
ly
lo
w
er
sI
C
A
M
fa
st
in
g
le
ve
ls
af
te
r
4
w
ee
ks
on
th
e
hi
gh
-p
ro
te
in
di
et
.N
o
ch
an
ge
s
in
C
R
P
or
in
SA
A
.
O
no
-M
oo
re
et
al
.[
25
]
U
S,
20
16
P
la
ce
bo
-c
on
tr
ol
le
d
cr
os
so
ve
r.
P
os
tp
ra
nd
ia
l
n
=
23
,n
or
m
al
w
ei
gh
t,
ag
ed
27
-3
3
yr
s.
65
0
ca
lo
ri
es
m
od
er
at
e
hi
gh
-f
at
br
ea
kf
as
t
(4
0%
fa
t)
w
it
h
pl
ac
eb
o
po
w
de
r
or
w
it
h
2
or
4
se
rv
in
gs
of
th
e
bl
ue
be
rr
y
po
w
de
r
se
rv
ed
in
yo
gu
rt
IL
-1
β
,I
L-
6,
IL
8,
an
d
T
N
F-
α
.
Fa
st
in
g
an
d
po
st
pr
an
di
al
(a
t
3.
5
H
)
T
he
re
w
er
e
no
su
bs
ta
nt
ia
le
ﬀ
ec
t
of
th
e
bl
ue
be
rr
y
po
w
de
r
on
th
e
po
st
pr
an
di
al
pl
as
m
a
cy
to
ki
ne
s
or
on
m
ar
ke
r
ex
pr
es
si
on
.
A
ll
cy
to
ki
ne
s
w
er
e
de
cr
ea
se
d
in
th
e
po
st
pr
an
di
al
st
at
e
co
m
pa
re
d
to
th
e
fa
st
in
g
st
at
e;
th
is
co
rr
el
at
es
w
it
h
de
cr
ea
se
d
FF
A
s
in
th
e
po
st
pr
an
di
al
st
at
e.
V
it
al
e
et
al
.[
54
]
It
al
y,
20
16
C
ro
ss
-s
ec
ti
on
al
.S
ub
se
td
at
a
fr
om
th
e
T
O
SC
A
.IT
st
ud
y.
n
=
17
85
,w
it
h
T
2D
,
ag
ed
50
-7
5
yr
s.
Fi
be
r,
ad
de
d
su
ga
r,
an
d
di
ﬀ
er
en
t
pr
op
or
ti
on
s
of
fa
t
an
d
C
H
O
.
hs
C
R
P
Fa
t
in
ta
ke
in
cr
ea
se
fr
om
25
to
35
%
or
m
or
e
is
as
so
ci
at
ed
w
it
h
an
in
cr
ea
si
ng
hs
C
R
P
;c
on
tr
ar
y
in
cr
ea
si
ng
C
H
O
45
%
to
60
%
or
m
or
e
w
as
as
so
ci
at
ed
w
it
h
lo
w
er
hs
C
R
P
.T
he
av
er
ag
e
G
I
of
pa
rt
ic
ip
an
ts
’d
ie
t
w
as
lo
w
.H
s-
C
R
P
in
cr
ea
se
s
pr
og
re
ss
iv
el
y
w
he
n
ad
de
d
su
ga
r
in
ta
ke
in
cr
ea
se
s.
Fi
be
r
in
tak
e>
15
g/
10
00
kc
al
is
as
so
ci
at
ed
w
it
h
lo
w
er
hs
C
R
P
.
C
or
m
ie
r
et
al
.[
62
]
C
an
ad
a,
20
16
O
m
eg
a-
3
P
U
FA
su
pp
le
m
en
t.
N
o
co
nt
ro
lg
ro
up
/6
w
ee
ks
.
Fa
tt
y
A
ci
d
Se
ns
or
St
ud
y.
n
=
19
1 ,
ag
ed
21
-3
9
yr
s.
,
B
M
I
ra
ng
e
24
-3
1.
5.
5
g/
d
of
ﬁ
sh
oi
ls
up
pl
em
en
t:
1.
9-
2.
1
g
of
E
P
A
an
d
1.
1
of
D
H
A
C
R
P
,I
L-
1,
T
N
F-
α
,
an
d
IL
-6
ge
ne
ex
pr
es
si
on
in
pe
ri
ph
er
al
m
on
on
uc
le
ar
ce
lls
T
he
re
w
er
e
no
re
du
ct
io
ns
in
pl
as
m
a
IL
-6
,C
R
P
,o
r
T
N
F-
α
po
st
in
te
rv
en
ti
on
.
P
la
sm
a
n-
3
le
ve
ls
w
er
e
ne
ga
ti
ve
ly
co
rr
el
at
ed
w
it
h
pl
as
m
a
cy
to
ki
ne
s
an
d
C
R
P
.
T
he
re
w
er
e
se
ve
ra
lg
en
e-
di
et
in
te
ra
ct
io
ns
w
it
h
SN
P
s
w
it
hi
n
in
ﬂ
am
m
at
io
n-
re
la
te
d
ge
ne
s
an
d
om
eg
a-
3,
bu
t
th
is
va
ri
ed
ac
co
rd
in
g
to
in
di
vi
du
al
ge
no
ty
pe
s.
6 Disease Markers
T
a
bl
e
2:
C
on
ti
nu
ed
.
A
ut
ho
rs
/o
ri
gi
n/
ye
ar
St
ud
y
de
si
gn
/d
ur
at
io
n
P
ar
ti
ci
pa
nt
s
N
ut
ri
en
t
In
ﬂ
am
m
at
or
y
m
ar
ke
rs
m
ea
su
re
d
R
es
ul
ts
H
os
se
in
ie
t
al
.[
22
]
Ir
an
,2
01
6
R
C
T
,d
ou
bl
e-
bl
in
d/
30
da
ys
in
te
rv
en
ti
on
n
=
48
,h
ea
lth
y
ad
ul
ts
,
ag
ed
30
-6
0
yr
s.
50
0
m
g
po
m
eg
ra
na
te
ex
tr
ac
t
(P
E
)
or
pl
ac
eb
o
(P
L)
.
M
D
A
,I
L-
6,
an
d
hs
C
R
P
T
he
P
E
gr
ou
p
lo
st
si
gn
iﬁ
ca
nt
ly
m
or
e
w
ei
gh
t
th
an
th
e
P
L.
T
he
m
ea
n
se
ru
m
co
nc
en
tr
at
io
n
of
M
D
A
,I
L-
6,
an
d
hs
C
R
P
de
cr
ea
se
d
si
gn
iﬁ
ca
nt
ly
in
th
e
P
E
gr
ou
p.
C
ha
ng
e
in
bo
dy
w
ei
gh
t
w
as
co
rr
el
at
ed
w
it
h
th
es
e
pa
ra
m
et
er
s.
D
e
Lo
re
nz
o
et
al
.[
63
]
It
al
y,
20
17
C
ro
ss
ov
er
R
C
T
po
st
pr
an
di
al
n
=
22
,h
ea
lth
y
T
oc
op
he
ro
l-
en
ri
ch
ed
M
ed
it
er
ra
ne
an
m
ea
l(
T
E
M
),
41
%
C
H
O
/1
6%
pr
ot
ei
n/
42
%
fa
t
vs
.
W
es
te
rn
hi
gh
-f
at
m
ea
l(
H
FM
),
27
%
C
H
O
/1
8%
pr
ot
ei
n/
55
%
fa
t.
G
en
es
of
th
e
in
ﬂ
am
m
as
om
e
pa
th
w
ay
an
d
ge
ne
s
of
th
e
ox
id
at
iv
e
st
re
ss
pa
th
w
ay
.F
as
ti
ng
an
d
po
st
pr
an
di
al
(a
t
3
H
)
A
si
ng
le
H
FM
re
su
lt
ed
in
up
re
gu
la
ti
on
of
th
e
hu
m
an
in
ﬂ
am
m
as
om
e
pa
th
w
ay
ge
ne
s
by
15
.4
%
an
d
of
th
e
hu
m
an
ox
id
at
iv
e
pa
th
w
ay
by
15
%
w
he
n
co
m
pa
re
d
w
it
h
a
T
E
M
.A
dd
it
io
na
lly
,
a
do
w
nr
eg
ul
at
io
n
of
C
C
L5
w
as
ob
se
rv
ed
af
te
r
th
e
T
E
M
vs
.t
he
H
FM
.
A
bb
re
vi
at
io
ns
.M
D
A
:m
al
on
di
al
de
hy
de
;P
R
O
P
R
E
S:
P
ro
te
in
an
d
bl
oo
d
pr
es
su
re
st
ud
y;
R
C
T
:r
an
do
m
iz
ed
,c
on
tr
ol
le
d
tr
ia
l;
SA
A
:s
er
um
am
yl
oi
d
A
;T
O
SC
A
.IT
:t
hi
az
ol
id
in
ed
io
ne
s
or
su
lfo
ny
lu
re
as
an
d
ca
rd
io
va
sc
ul
ar
ac
ci
de
nt
in
te
rv
en
ti
on
tr
ia
l.
7Disease Markers
3.1. Dietary Macronutrient Distribution and Inﬂammation.
Modulation of macronutrient ratios is a wide-reaching and
impactful dietary variable to test. A cross-sectional study per-
formed on 1785 people with type 2 diabetes mellitus (T2DM)
explored the association of metabolic risk factors vs. fat and
carbohydrate proportions of the diet. The authors reported
that a ﬁber intake ≥ 15 g/1000 kcal was associated with lower
CRP, whereas added sugar consumption higher than 10%
was associated with higher CRP [54]. Increased fat intake
was additionally associated with higher CRP; however,
authors did not include a description of the type of the
dietary fat (MUFA vs. PUFA vs. SFA) [54]. This study had
limitations in that the researchers set arbitrary macronutrient
cutoﬀs for tertile analysis, leading to drastically diﬀerent
sample sizes between macronutrient intake groups. The
authors divided the macronutrients of interest into arbitrary
categories, the cutoﬀ points were <25%, 25–34%, or ≥35% for
total fat intake; <45%, 45–59%, or ≥60% for CHO; <10,
10–14, or ≥15 g/1000 kcal for ﬁber; and <5%, 5–9%, or
≥10% for added sugar. In the extreme of the tertiles, e.g.,
group of >60% CHO (n = 12) and for fat <25% (n = 15) vs.
the other groups that had hundreds of participants. Addi-
tional studies have observed signiﬁcant reductions in
inﬂammatory markers in T2DM and coronary heart dis-
ease populations following carbohydrate-restricted diets
(which are consequently rich in fat and protein), although
these ﬁndings may be confounded by concurrent weight
loss [55, 56].
3.2. Eﬀects of Bioactive Nutrients and Functional Foods on
Inﬂammation. Beyond macronutrient distribution, bioactive
compounds provided in isolated forms, or as components of
functional foods, further contribute to the pro and anti-
inﬂammatory properties of dietary patterns. A 6-week inter-
vention of omega-3 PUFA supplementation provided as
5 g/day of ﬁsh oil did not have an impact on inﬂammatory
biomarker levels in overweight participants [62]. Meanwhile,
a randomized, controlled trial (RCT) evaluating the eﬀect of
30-day polyphenol-rich pomegranate extract supplementa-
tion in overweight and obese individuals resulted in weight
loss and reductions in IL-6, CRP, and malondialdehyde
(MDA) [22]. Thus, body fat reduction may be a confounding
factor in determining the eﬀects of the supplement. In
healthy people, a crossover trial tested the postprandial
eﬀects of one Mediterranean meal that was rich in tocopherol
vs. a “Western meal” high in fat on mRNA expression
of genes involved in the inﬂammasome pathway [63].
Researchers reported an upregulation of inﬂammasome
gene expression following consumption of the high-fat
meal. Similarly, changes in fasting plasma biomarkers were
reported in another study after 4 weeks of consuming an
isocaloric Mediterranean vs. high-fat breakfast in a group
of overweight individuals [64]. Results from these studies
illustrate the importance of including postprandial testing
when evaluating the eﬀect of foods. Adding antioxidants,
such as polyphenols, to a high-fat meal could attenuate
the postprandial inﬂammatory response; however, a cross-
over study testing polyphenol supplementation in healthy
individuals failed to show this protective eﬀect [25].
4. Considerations for Population-Specific
Dietary Recommendations and
Future Studies
Most results from epidemiological and cross-sectional stud-
ies showed associations between diet quality and inﬂamma-
tory markers. Conversely, ﬁndings from the recent RCTs
highlighted in this review show discrepancies in changes of
fasting plasma cytokines in healthy [59], obese [41, 57],
diabetic [55, 56], and CHD [56] individuals in response to
diet. In the following section, we provide a critical analysis
of factors that may contribute to the variability across studies
and highlight considerations for study design when evaluat-
ing dietary patterns moving forward.
4.1. Metabolic Status. Obese individuals and/or persons with
metabolic abnormalities, including diabetes or metabolic
syndrome (MetS), appear to be the main target population
to study the eﬀect of diet and inﬂammation. The response
to a meal challenge, such as a “traditional” Brazilian SFA-
rich breakfast vs. a breakfast of highly unsaturated fats and
ﬁber, diﬀers based on the metabolic status of people with
MetS [64]. The authors concluded the need for using diﬀer-
ent biomarkers when examining responses to dietary inter-
ventions of individuals at diﬀerent levels of CVD risk. As
an example, an 8-week weight loss intervention conducted
with obese MetS participants resulted in changes in plasma
MDA and plasminogen activator inhibitor-1 (PAI-1), but
additionally did not show decreases in CRP and IL-6 [41].
Conversely, weight loss in overweight individuals without a
MetS classiﬁcation has been shown to lower CRP [65]. To
further illustrate the complexity of how the same food could
aﬀect individuals diﬀerently, in a comprehensive review
about bioactive egg components and inﬂammation, we have
previously reported that the majority of research suggests
that egg intake promotes a neutral or proinﬂammatory
response in healthy adults, whereas those with metabolic
abnormalities have either an anti-inﬂammatory or a neutral
eﬀect. It is possible that this variation is attributable to diﬀer-
ences in intestinal absorption of dietary cholesterol, or other
factors such as the composition of the microbiome or genetic
variation [24].
As mentioned above, people with metabolic disorders
participated in the majority of the studies evaluating associa-
tions of diet with inﬂammatory biomarkers [41, 51, 54, 61]. It
appears that if low-grade, systemic inﬂammation is present,
then certain modiﬁcations in the diet could ameliorate it;
however, this is not as clear with regard to prevention of
inﬂammation. There were few studies done in healthy indi-
viduals and the responses, as expected, were diﬀerent from
those seen in people with metabolic disorders. The majority
of studies analyzed in the present review conducted with
healthy individuals show no eﬀects of dietary patterns and
individual components on inﬂammatory markers. One
possible reason could be that the cytokines were not elevated
to begin with and/or that the dietary challenges did not cause
a signiﬁcant inﬂammatory response in these populations due
to diﬀerences in genetics, microbiome proﬁles, and overall
metabolic and immune health. In healthy people with normal
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levels of inﬂammatory markers, a short diet intervention
(6 weeks) did not change plasma inﬂammatory markers
[59]. Similarly, there were no changes in plasma IL-6,
CRP, or TNF-α in a group of 191 overweight individuals
receiving omega-3 PUFA supplementation for 6 weeks
[62]. Meanwhile, some studies performed in healthy people
in other individual nutrients reported improvement such
as blueberries [25], pomegranates [22], and tocopherol-
enriched meals [63].
4.2. Need for Comprehensive Inﬂammatory Biomarker
Assessment. Discrepancies in diet-induced eﬀects on inﬂam-
mation may further be attributed to diﬀerences in measured
biomarkers. A review by Calder et al. [66] discussed the
importance of measuring many biomarkers to capture
changes, since there may be speciﬁc inﬂammatory markers
associated with each chronic disease. For example, Van
Bussel et al. [67] used a combination of biomarkers to gener-
ate a “low-grade inﬂammatory score” in order to examine
associations between food groups and inﬂammation in a
subset of 557 participants with increased risk of CAD within
the CODAM (Cohort of Diabetes and Atherosclerosis
Maastricht) observational study. Consumption of vegetables,
fruit, wine (in moderation), and poultry, as well as lower
intake of meat and high-fat dairy products, was associated
with a lower “low-grade inﬂammatory score.” Shivappa
et al. [60] also used a composite score called an INFLA score
(including CRP, leukocytes count, and granulocyte to lym-
phocyte ratio), which was positively associated with DII, in
20,823 adults from the Moli-sani study. Interestingly, there
was no association between food groups and CRP alone
[60]. These ﬁndings emphasize the need for comprehensive
and condition-speciﬁc assessment of inﬂammatory markers
in evaluating the eﬀects of dietary patterns.
4.3. Role of Weight Loss in Assessing Anti-Inﬂammatory
Eﬀects of Dietary Patterns. Another confounding factor in
investigating the relationship between diet and inﬂammation
is weight loss. If the interventions [22, 68, 69] include weight
loss as an outcome, it may be diﬃcult to pinpoint the actual
diet as the main contributor to the reduction in inﬂammatory
cytokines. It is well established that waist circumference is
associated with CRP and that body fat reduction amelio-
rates low-grade inﬂammation [1, 70, 71]. More speciﬁcally,
changes in CRP levels in response to diet have found to be
dependent on weight loss [72]. Indeed, studies reporting an
improvement in inﬂammation with diet had participants
losing weight, which could have been driven by the reduction
in adipose tissue mass and function [22, 55, 57, 73].
4.4. Fasting vs. Postprandial Eﬀects of Diet on Inﬂammation.
Most of the studies in the present review [22, 54, 62] reported
inﬂammatory markers only in the fasting state. As suggested
by Minihane et al. [74], assessing biomarkers in response to a
dietary challenge may provide a better picture of the actual
eﬀect of the diet. We also distinguished studies measuring
cytokines in the postprandial state [63] and both (postpran-
dial and fasting) [25, 61]. For example, a study measured
the eﬀect of polyphenols from blueberry powder served in
yogurt in the fasting and postprandial state. All cytokines
were decreased in the postprandial state compared to the
fasting state [25]. Likewise, a study examined chronic (mea-
sured at fasting) and postprandial eﬀects of a protein mixture
compared with carbohydrate intake (placebo) on inﬂamma-
tory markers. Postprandial CRP levels were higher 4 hours
after ingestion of the protein mix compared to maltodextrin.
Meanwhile, at fasting levels after 4 weeks on the high protein
diet, there were no changes in fasting plasma CRP or in SAA
[61]. A recent review evaluating the eﬀect of fruit-based
drinks in postprandial studies details some risks of misinter-
pretation inherent to measure nutrient in the postprandial
state [75].
4.5. Dietary Compliance. Similarly to pharmaceutical trials, a
dose/eﬀect is relevant when assessing the anti-inﬂammatory
potential of a diet [76]. Based on the evidence presented,
emphasis should be given to dietary adherence, as a lack
of adherence to experimental diets may confound results
and contribute to variability observed between studies.
Researchers evaluating diet and inﬂammatory markers
must address this factor by providing study participants with
strategies to increase dietary adherence, while further imple-
menting an eﬀective procedure to measure compliance [77].
In the case of observational studies, it is crucial to have an
appropriate and validated method to collect dietary intake
data and a systematic way to enter and analyze the data.
4.6. Additional Factors. There may be a threat to the validity
of results about the eﬀect of diet in participants taking
medications that aﬀect inﬂammation or who have genetic
variants that impact physiological and inﬂammatory
responses to dietary components. Even though data are
adjusted for confounding factors such as lipid-lowering med-
ications, energy intake, or waist circumference, the eﬀect of
the diet may be blurred by those factors [78, 79]. Speciﬁc
nutrients such as ﬁber or antioxidants may further exert a
positive eﬀect through their inﬂuence on the microbiota.
The key role of the microbiota is not included in the scope
of the present review; however, other reviews [20, 80] contain
discussions on the eﬀects of the microbiota on inﬂammation.
The complexity of the global relationship between diet and
inﬂammation cannot be bypassed.
5. Conclusions and Practical Implications
We observe vast evidence from observational studies on the
correlation between a healthy dietary pattern and inﬂamma-
tory markers. The high variability in the study designs and
the population makes it diﬃcult to generalize the results from
the present review. Most data available on dietary patterns
are observational. Ideally, though costly, conducting RCTs
in healthy, overweight/obese, T2DM, and CVD individuals
and measuring several biomarkers in the fasting and the
postprandial state, including genotyping, would contribute
to better understanding the eﬀect diet has, as a whole,
on inﬂammation.
Perhaps, having a proxy such as using a healthy eating
score, such as the DII, could be an alternative to a more costly
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laboratory cytokine evaluation in clinical practice, if vali-
dated for these purposes. Comparing the patient diet with
the DII score provides valuable information regarding the
inﬂammatory potential of the diet and areas for improve-
ment. Indeed, there is a group of researchers from South
Carolina who translated their research into an educational
platform, oﬀering innovative products that can be used by
health care providers and the public in order to better under-
stand the inﬂammatory potential of the diet [81]. The last
International Life Sciences Institute (ILSI) position paper
provided a list of topics to address when building a dossier
for a European Food Safety Authority health claim on control
of chronic low-grade inﬂammation [74]. This suggests that
Europe is considering adding an “inﬂammatory index” in
labels. These trends in policy support key research ﬁndings
that diet is a low-cost, preventative, and therapeutic target
that must be stressed considering the role that low-grade, sys-
temic inﬂammation has in highly prevalent chronic diseases.
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